The global Hyperimmune Globulins market is projected to grow from US$ 1821.6 million in 2023 to US$ 2733.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.

Hyperimmune Globulins Market

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

Report Includes:

This report presents an overview of global market for Hyperimmune Globulins, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Hyperimmune Globulins, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Hyperimmune Globulins, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hyperimmune Globulins sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Hyperimmune Globulins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Hyperimmune Globulins sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

Scope of Hyperimmune Globulins Market Report

Report Metric	Details
Report Name	Hyperimmune Globulins Market
Accounted market size in 2023	US$ 1821.6 million
Forecasted market size in 2029	US$ 2733.7 million
CAGR	7.0
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Hepatitis B Immunoglobulins Rabies Immunoglobulins Tetanus Immunoglobulins Rho(D) Immunoglobulins Other
Segment by Application	Government Institutions Private Sector Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hyperimmune Globulins in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulins sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Hyperimmune Globulins Market growing?

Ans: The Hyperimmune Globulins Market witnessing a CAGR of 7.0 during the forecast period 2023-2029.

What is the Hyperimmune Globulins Market size in 2029?

Ans: The Hyperimmune Globulins Market size in 2029 will be US$ 2733.7 million.

What is the market share of major companies in Hyperimmune Globulins Market?

Ans: Global top two manufacturers hold a share over 50%.

Who are the main players in the Hyperimmune Globulins Market report?

Ans: The main players in the Hyperimmune Globulins Market are CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Hyperimmune Globulins Market report?

Ans: The Applications covered in the Hyperimmune Globulins Market report are Government Institutions, Private Sector, Other

What are the Type segmentation covered in the Hyperimmune Globulins Market report?

Ans: The Types covered in the Hyperimmune Globulins Market report are Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Other

1 Study Coverage

1.1 Hyperimmune Globulins Product Introduction

1.2 Market by Type

1.2.1 Global Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Hepatitis B Immunoglobulins

1.2.3 Rabies Immunoglobulins

1.2.4 Tetanus Immunoglobulins

1.2.5 Rho(D) Immunoglobulins

1.2.6 Other

1.3 Market by Application

1.3.1 Global Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Government Institutions

1.3.3 Private Sector

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Hyperimmune Globulins Sales Estimates and Forecasts 2018-2029

2.2 Global Hyperimmune Globulins Revenue by Region

2.2.1 Global Hyperimmune Globulins Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Hyperimmune Globulins Revenue by Region (2018-2023)

2.2.3 Global Hyperimmune Globulins Revenue by Region (2024-2029)

2.2.4 Global Hyperimmune Globulins Revenue Market Share by Region (2018-2029)

2.3 Global Hyperimmune Globulins Sales Estimates and Forecasts 2018-2029

2.4 Global Hyperimmune Globulins Sales by Region

2.4.1 Global Hyperimmune Globulins Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Hyperimmune Globulins Sales by Region (2018-2023)

2.4.3 Global Hyperimmune Globulins Sales by Region (2024-2029)

2.4.4 Global Hyperimmune Globulins Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Hyperimmune Globulins Sales by Manufacturers

3.1.1 Global Hyperimmune Globulins Sales by Manufacturers (2018-2023)

3.1.2 Global Hyperimmune Globulins Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hyperimmune Globulins in 2022

3.2 Global Hyperimmune Globulins Revenue by Manufacturers

3.2.1 Global Hyperimmune Globulins Revenue by Manufacturers (2018-2023)

3.2.2 Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Hyperimmune Globulins Revenue in 2022

3.3 Global Key Players of Hyperimmune Globulins, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Hyperimmune Globulins Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Hyperimmune Globulins, Product Offered and Application

3.8 Global Key Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Hyperimmune Globulins Sales by Type

4.1.1 Global Hyperimmune Globulins Historical Sales by Type (2018-2023)

4.1.2 Global Hyperimmune Globulins Forecasted Sales by Type (2024-2029)

4.1.3 Global Hyperimmune Globulins Sales Market Share by Type (2018-2029)

4.2 Global Hyperimmune Globulins Revenue by Type

4.2.1 Global Hyperimmune Globulins Historical Revenue by Type (2018-2023)

4.2.2 Global Hyperimmune Globulins Forecasted Revenue by Type (2024-2029)

4.2.3 Global Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

4.3 Global Hyperimmune Globulins Price by Type

4.3.1 Global Hyperimmune Globulins Price by Type (2018-2023)

4.3.2 Global Hyperimmune Globulins Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Hyperimmune Globulins Sales by Application

5.1.1 Global Hyperimmune Globulins Historical Sales by Application (2018-2023)

5.1.2 Global Hyperimmune Globulins Forecasted Sales by Application (2024-2029)

5.1.3 Global Hyperimmune Globulins Sales Market Share by Application (2018-2029)

5.2 Global Hyperimmune Globulins Revenue by Application

5.2.1 Global Hyperimmune Globulins Historical Revenue by Application (2018-2023)

5.2.2 Global Hyperimmune Globulins Forecasted Revenue by Application (2024-2029)

5.2.3 Global Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

5.3 Global Hyperimmune Globulins Price by Application

5.3.1 Global Hyperimmune Globulins Price by Application (2018-2023)

5.3.2 Global Hyperimmune Globulins Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Hyperimmune Globulins Market Size by Type

6.1.1 US & Canada Hyperimmune Globulins Sales by Type (2018-2029)

6.1.2 US & Canada Hyperimmune Globulins Revenue by Type (2018-2029)

6.2 US & Canada Hyperimmune Globulins Market Size by Application

6.2.1 US & Canada Hyperimmune Globulins Sales by Application (2018-2029)

6.2.2 US & Canada Hyperimmune Globulins Revenue by Application (2018-2029)

6.3 US & Canada Hyperimmune Globulins Market Size by Country

6.3.1 US & Canada Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Hyperimmune Globulins Sales by Country (2018-2029)

6.3.3 US & Canada Hyperimmune Globulins Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Hyperimmune Globulins Market Size by Type

7.1.1 Europe Hyperimmune Globulins Sales by Type (2018-2029)

7.1.2 Europe Hyperimmune Globulins Revenue by Type (2018-2029)

7.2 Europe Hyperimmune Globulins Market Size by Application

7.2.1 Europe Hyperimmune Globulins Sales by Application (2018-2029)

7.2.2 Europe Hyperimmune Globulins Revenue by Application (2018-2029)

7.3 Europe Hyperimmune Globulins Market Size by Country

7.3.1 Europe Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Hyperimmune Globulins Sales by Country (2018-2029)

7.3.3 Europe Hyperimmune Globulins Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Hyperimmune Globulins Market Size

8.1.1 China Hyperimmune Globulins Sales (2018-2029)

8.1.2 China Hyperimmune Globulins Revenue (2018-2029)

8.2 China Hyperimmune Globulins Market Size by Application

8.2.1 China Hyperimmune Globulins Sales by Application (2018-2029)

8.2.2 China Hyperimmune Globulins Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Hyperimmune Globulins Market Size by Type

9.1.1 Asia Hyperimmune Globulins Sales by Type (2018-2029)

9.1.2 Asia Hyperimmune Globulins Revenue by Type (2018-2029)

9.2 Asia Hyperimmune Globulins Market Size by Application

9.2.1 Asia Hyperimmune Globulins Sales by Application (2018-2029)

9.2.2 Asia Hyperimmune Globulins Revenue by Application (2018-2029)

9.3 Asia Hyperimmune Globulins Sales by Region

9.3.1 Asia Hyperimmune Globulins Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Hyperimmune Globulins Revenue by Region (2018-2029)

9.3.3 Asia Hyperimmune Globulins Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Hyperimmune Globulins Market Size by Type

10.1.1 Middle East, Africa and Latin America Hyperimmune Globulins Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Hyperimmune Globulins Market Size by Application

10.2.1 Middle East, Africa and Latin America Hyperimmune Globulins Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country

10.3.1 Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 CSL Behring

11.1.1 CSL Behring Company Information

11.1.2 CSL Behring Overview

11.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 CSL Behring Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 CSL Behring Recent Developments

11.2 Grifols

11.2.1 Grifols Company Information

11.2.2 Grifols Overview

11.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Grifols Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Grifols Recent Developments

11.3 Biotest

11.3.1 Biotest Company Information

11.3.2 Biotest Overview

11.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Biotest Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Biotest Recent Developments

11.4 Kedrion

11.4.1 Kedrion Company Information

11.4.2 Kedrion Overview

11.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Kedrion Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Kedrion Recent Developments

11.5 CBPO

11.5.1 CBPO Company Information

11.5.2 CBPO Overview

11.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 CBPO Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 CBPO Recent Developments

11.6 Emergent (Cangene)

11.6.1 Emergent (Cangene) Company Information

11.6.2 Emergent (Cangene) Overview

11.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Emergent (Cangene) Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Emergent (Cangene) Recent Developments

11.7 Kamada

11.7.1 Kamada Company Information

11.7.2 Kamada Overview

11.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Kamada Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Kamada Recent Developments

11.8 CNBG

11.8.1 CNBG Company Information

11.8.2 CNBG Overview

11.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 CNBG Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 CNBG Recent Developments

11.9 Hualan Bio

11.9.1 Hualan Bio Company Information

11.9.2 Hualan Bio Overview

11.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.9.4 Hualan Bio Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Hualan Bio Recent Developments

11.10 Shanghai RAAS

11.10.1 Shanghai RAAS Company Information

11.10.2 Shanghai RAAS Overview

11.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.10.4 Shanghai RAAS Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Shanghai RAAS Recent Developments

11.11 Sichuan Yuanda Shuyang

11.11.1 Sichuan Yuanda Shuyang Company Information

11.11.2 Sichuan Yuanda Shuyang Overview

11.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Sichuan Yuanda Shuyang Recent Developments

11.12 ADMA Biologics

11.12.1 ADMA Biologics Company Information

11.12.2 ADMA Biologics Overview

11.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2023)

11.12.4 ADMA Biologics Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 ADMA Biologics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Hyperimmune Globulins Industry Chain Analysis

12.2 Hyperimmune Globulins Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Hyperimmune Globulins Production Mode & Process

12.4 Hyperimmune Globulins Sales and Marketing

12.4.1 Hyperimmune Globulins Sales Channels

12.4.2 Hyperimmune Globulins Distributors

12.5 Hyperimmune Globulins Customers

13 Market Dynamics

13.1 Hyperimmune Globulins Industry Trends

13.2 Hyperimmune Globulins Market Drivers

13.3 Hyperimmune Globulins Market Challenges

13.4 Hyperimmune Globulins Market Restraints

14 Key Findings in The Global Hyperimmune Globulins Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

ADMA Biologics

List of Tables

Table 1. Global Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Hepatitis B Immunoglobulins

Table 3. Major Manufacturers of Rabies Immunoglobulins

Table 4. Major Manufacturers of Tetanus Immunoglobulins

Table 5. Major Manufacturers of Rho(D) Immunoglobulins

Table 6. Major Manufacturers of Other

Table 7. Global Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Hyperimmune Globulins Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. Global Hyperimmune Globulins Revenue by Region (2018-2023) & (US$ Million)

Table 10. Global Hyperimmune Globulins Revenue by Region (2024-2029) & (US$ Million)

Table 11. Global Hyperimmune Globulins Revenue Market Share by Region (2018-2023)

Table 12. Global Hyperimmune Globulins Revenue Market Share by Region (2024-2029)

Table 13. Global Hyperimmune Globulins Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 14. Global Hyperimmune Globulins Sales by Region (2018-2023) & (K Units)

Table 15. Global Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)

Table 16. Global Hyperimmune Globulins Sales Market Share by Region (2018-2023)

Table 17. Global Hyperimmune Globulins Sales Market Share by Region (2024-2029)

Table 18. Global Hyperimmune Globulins Sales by Manufacturers (2018-2023) & (K Units)

Table 19. Global Hyperimmune Globulins Sales Share by Manufacturers (2018-2023)

Table 20. Global Hyperimmune Globulins Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 21. Global Hyperimmune Globulins Revenue Share by Manufacturers (2018-2023)

Table 22. Global Key Players of Hyperimmune Globulins, Industry Ranking, 2021 VS 2022 VS 2023

Table 23. Hyperimmune Globulins Price by Manufacturers 2018-2023 (USD/Unit)

Table 24. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2022)

Table 26. Global Key Manufacturers of Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Hyperimmune Globulins, Product Offered and Application

Table 28. Global Key Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 31. Global Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 32. Global Hyperimmune Globulins Sales Share by Type (2018-2023)

Table 33. Global Hyperimmune Globulins Sales Share by Type (2024-2029)

Table 34. Global Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 35. Global Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 36. Global Hyperimmune Globulins Revenue Share by Type (2018-2023)

Table 37. Global Hyperimmune Globulins Revenue Share by Type (2024-2029)

Table 38. Hyperimmune Globulins Price by Type (2018-2023) & (USD/Unit)

Table 39. Global Hyperimmune Globulins Price Forecast by Type (2024-2029) & (USD/Unit)

Table 40. Global Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 41. Global Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 42. Global Hyperimmune Globulins Sales Share by Application (2018-2023)

Table 43. Global Hyperimmune Globulins Sales Share by Application (2024-2029)

Table 44. Global Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 45. Global Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 46. Global Hyperimmune Globulins Revenue Share by Application (2018-2023)

Table 47. Global Hyperimmune Globulins Revenue Share by Application (2024-2029)

Table 48. Hyperimmune Globulins Price by Application (2018-2023) & (USD/Unit)

Table 49. Global Hyperimmune Globulins Price Forecast by Application (2024-2029) & (USD/Unit)

Table 50. US & Canada Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 51. US & Canada Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 52. US & Canada Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 53. US & Canada Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 54. US & Canada Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 55. US & Canada Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 56. US & Canada Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 57. US & Canada Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 58. US & Canada Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 59. US & Canada Hyperimmune Globulins Revenue by Country (2018-2023) & (US$ Million)

Table 60. US & Canada Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)

Table 61. US & Canada Hyperimmune Globulins Sales by Country (2018-2023) & (K Units)

Table 62. US & Canada Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)

Table 63. Europe Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 64. Europe Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 65. Europe Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 66. Europe Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 67. Europe Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 68. Europe Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 69. Europe Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 70. Europe Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 71. Europe Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 72. Europe Hyperimmune Globulins Revenue by Country (2018-2023) & (US$ Million)

Table 73. Europe Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)

Table 74. Europe Hyperimmune Globulins Sales by Country (2018-2023) & (K Units)

Table 75. Europe Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)

Table 76. China Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 77. China Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 78. China Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 79. China Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 80. China Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 81. China Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 82. China Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 83. China Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 84. Asia Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 85. Asia Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 86. Asia Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 87. Asia Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 88. Asia Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 89. Asia Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 90. Asia Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 91. Asia Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 92. Asia Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 93. Asia Hyperimmune Globulins Revenue by Region (2018-2023) & (US$ Million)

Table 94. Asia Hyperimmune Globulins Revenue by Region (2024-2029) & (US$ Million)

Table 95. Asia Hyperimmune Globulins Sales by Region (2018-2023) & (K Units)

Table 96. Asia Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)

Table 97. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Type (2018-2023) & (K Units)

Table 98. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)

Table 99. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Type (2018-2023) & (US$ Million)

Table 100. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)

Table 101. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Application (2018-2023) & (K Units)

Table 102. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)

Table 103. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Application (2018-2023) & (US$ Million)

Table 104. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)

Table 105. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 106. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country (2018-2023) & (US$ Million)

Table 107. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)

Table 108. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country (2018-2023) & (K Units)

Table 109. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)

Table 110. CSL Behring Company Information

Table 111. CSL Behring Description and Major Businesses

Table 112. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 113. CSL Behring Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. CSL Behring Recent Developments

Table 115. Grifols Company Information

Table 116. Grifols Description and Major Businesses

Table 117. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 118. Grifols Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Grifols Recent Developments

Table 120. Biotest Company Information

Table 121. Biotest Description and Major Businesses

Table 122. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 123. Biotest Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Biotest Recent Developments

Table 125. Kedrion Company Information

Table 126. Kedrion Description and Major Businesses

Table 127. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 128. Kedrion Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Kedrion Recent Developments

Table 130. CBPO Company Information

Table 131. CBPO Description and Major Businesses

Table 132. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 133. CBPO Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. CBPO Recent Developments

Table 135. Emergent (Cangene) Company Information

Table 136. Emergent (Cangene) Description and Major Businesses

Table 137. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 138. Emergent (Cangene) Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Emergent (Cangene) Recent Developments

Table 140. Kamada Company Information

Table 141. Kamada Description and Major Businesses

Table 142. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 143. Kamada Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Kamada Recent Developments

Table 145. CNBG Company Information

Table 146. CNBG Description and Major Businesses

Table 147. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 148. CNBG Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. CNBG Recent Developments

Table 150. Hualan Bio Company Information

Table 151. Hualan Bio Description and Major Businesses

Table 152. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 153. Hualan Bio Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Hualan Bio Recent Developments

Table 155. Shanghai RAAS Company Information

Table 156. Shanghai RAAS Description and Major Businesses

Table 157. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 158. Shanghai RAAS Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Shanghai RAAS Recent Developments

Table 160. Sichuan Yuanda Shuyang Company Information

Table 161. Sichuan Yuanda Shuyang Description and Major Businesses

Table 162. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 163. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Sichuan Yuanda Shuyang Recent Developments

Table 165. ADMA Biologics Company Information

Table 166. ADMA Biologics Description and Major Businesses

Table 167. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 168. ADMA Biologics Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. ADMA Biologics Recent Developments

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. Hyperimmune Globulins Distributors List

Table 173. Hyperimmune Globulins Customers List

Table 174. Hyperimmune Globulins Market Trends

Table 175. Hyperimmune Globulins Market Drivers

Table 176. Hyperimmune Globulins Market Challenges

Table 177. Hyperimmune Globulins Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyperimmune Globulins Product Picture

Figure 2. Global Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Hyperimmune Globulins Market Share by Type in 2022 & 2029

Figure 4. Hepatitis B Immunoglobulins Product Picture

Figure 5. Rabies Immunoglobulins Product Picture

Figure 6. Tetanus Immunoglobulins Product Picture

Figure 7. Rho(D) Immunoglobulins Product Picture

Figure 8. Other Product Picture

Figure 9. Global Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 10. Global Hyperimmune Globulins Market Share by Application in 2022 & 2029

Figure 11. Government Institutions

Figure 12. Private Sector

Figure 13. Other

Figure 14. Hyperimmune Globulins Report Years Considered

Figure 15. Global Hyperimmune Globulins Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Hyperimmune Globulins Revenue 2018-2029 (US$ Million)

Figure 17. Global Hyperimmune Globulins Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 18. Global Hyperimmune Globulins Revenue Market Share by Region (2018-2029)

Figure 19. Global Hyperimmune Globulins Sales 2018-2029 ((K Units)

Figure 20. Global Hyperimmune Globulins Sales Market Share by Region (2018-2029)

Figure 21. US & Canada Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)

Figure 22. US & Canada Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)

Figure 23. Europe Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)

Figure 24. Europe Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)

Figure 25. China Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)

Figure 26. China Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)

Figure 27. Asia (excluding China) Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)

Figure 28. Asia (excluding China) Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)

Figure 30. Middle East, Africa and Latin America Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)

Figure 31. The Hyperimmune Globulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 32. The Top 5 and 10 Largest Manufacturers of Hyperimmune Globulins in the World: Market Share by Hyperimmune Globulins Revenue in 2022

Figure 33. Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 34. Global Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 35. Global Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 36. Global Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 37. Global Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 38. US & Canada Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 39. US & Canada Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 40. US & Canada Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 41. US & Canada Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 42. US & Canada Hyperimmune Globulins Revenue Share by Country (2018-2029)

Figure 43. US & Canada Hyperimmune Globulins Sales Share by Country (2018-2029)

Figure 44. U.S. Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 45. Canada Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 46. Europe Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 47. Europe Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 48. Europe Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 49. Europe Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 50. Europe Hyperimmune Globulins Revenue Share by Country (2018-2029)

Figure 51. Europe Hyperimmune Globulins Sales Share by Country (2018-2029)

Figure 52. Germany Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 53. France Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 54. U.K. Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 55. Italy Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 56. Russia Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 57. China Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 58. China Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 59. China Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 60. China Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 61. Asia Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 62. Asia Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 63. Asia Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 64. Asia Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 65. Asia Hyperimmune Globulins Revenue Share by Region (2018-2029)

Figure 66. Asia Hyperimmune Globulins Sales Share by Region (2018-2029)

Figure 67. Japan Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 68. South Korea Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 69. China Taiwan Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 70. Southeast Asia Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 71. India Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Hyperimmune Globulins Sales Market Share by Type (2018-2029)

Figure 73. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Market Share by Type (2018-2029)

Figure 74. Middle East, Africa and Latin America Hyperimmune Globulins Sales Market Share by Application (2018-2029)

Figure 75. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Market Share by Application (2018-2029)

Figure 76. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Share by Country (2018-2029)

Figure 77. Middle East, Africa and Latin America Hyperimmune Globulins Sales Share by Country (2018-2029)

Figure 78. Brazil Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 79. Mexico Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 80. Turkey Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 81. Israel Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 82. GCC Countries Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)

Figure 83. Hyperimmune Globulins Value Chain

Figure 84. Hyperimmune Globulins Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Hydroxycamptothecin - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-21F13841

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Ampoules and Syringes - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-20J6982

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Urokinase - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Z9012

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Animal Blood Plasma Products and Derivatives - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-34E6831

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions